EMILY ANKROM: Open Payments
NPI 1962803890 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$87,575 in 254 payments from 15 companies in 2025. Trend: 2023 $18,221 · 2024 $41,644 · 2025 $87,575
Speaker / faculty: $68,507Travel & lodging: $14,155Food & beverage: $4,613Consulting: $300
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 86 | $42,048 |
| Janssen Biotech, Inc. | 54 | $16,656 |
| Lilly USA, LLC | 39 | $15,553 |
| Takeda Pharmaceuticals U.S.A., Inc. | 31 | $12,489 |
| PFIZER INC. | 10 | $164 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $156 |
| Celltrion USA Inc. | 6 | $135 |
| Braintree Laboratories, Inc. | 1 | $76 |
| Regeneron Healthcare Solutions, Inc. | 2 | $69 |
| GENZYME CORPORATION | 2 | $60 |
Products named: SKYRIZI, RINVOQ, TREMFYA, OMVOH, ENTYVIO, XIFAXAN, VEGZELMA, DUPIXENT.
Industry payments across OH — which companies pay providers there.
